Sponsor or institution
Clinical trials and research at Samsung Bioepis Co., Ltd.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Samsung Bioepis Co., Ltd. that are recruiting, at sites in 4 countries (most in South Korea (2), Australia (1), Spain (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 4Countries
All recruiting trials (2)
-
Ixekizumab biosimilar SB35 vs Taltz: a single-dose PK and safety check in healthy adults
This study tests whether the biosimilar SB35 behaves the same as Taltz in how the drug acts in the body and how well it is tolerated in healthy adults.
-
E303 safety in people with advanced refractory solid tumors
This Phase I trial will test whether the drug E303 is safe and tolerable in people with advanced solid tumors who have not responded to or cannot receive standard treatments.
Quick answers
How many clinical trials run by Samsung Bioepis Co., Ltd. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in South Korea (2 trials), Australia (1 trial), Spain (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.